Rubius Therapeutics is a biopharmaceutical company that specializes in red cell therapeutics for severe diseases. Their developmental pipeline includes treatments for solid tumor cancer, HPV-positive tumors, and type 1 diabetes. Founded in 2013, the company is based in Cambridge, Massachusetts.